Final analysis of a randomized, double blind, phase II study of sorafenib with or without YIV-906 in patients with advanced HCC Meeting Abstract

  

Authors:	Abou-Alfa, G. K.; Yen, Y.; Harding, J. J.; Whang-Peng, J.; Shi, Y. K.; Yuen, M. F.; Li, X.; Gu, S.; Liu, C.; Jeng, L. B.; Yen, C. J.; Pan, C.; Chen, S. C.; Hsieh, J. C. H.; Saif, W. M.; Liu, S. H.; Li, F.; Lam, W.; Chu, E.; Cheng, Y. C.
Abstract Title:	Final analysis of a randomized, double blind, phase II study of sorafenib with or without YIV-906 in patients with advanced HCC
Meeting Title:	Ann. Oncol.
Journal Title:	Annals of Oncology
Volume:	36
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2025-07-01
Language:	English
ACCESSION:	WOS:001545612500029
DOI:	10.1016/j.annonc.2025.05.185
PROVIDER:	wos
Notes:	Meeting Abstract -- 1 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/228871